Overall, when administering GLP-1RA plus SGLT2i combination therapy, it is important to adopt an individualized approach to therapy taking into account individual preferences, costs and coverage, AE profile, consideration of kidney function and glucose-lowering efficacy, desire for weight loss, and comorbidities such as frailty [6, 22, 24]
GLP-1 (Glucagon-Like Peptide-1) medications mimic an incretin hormone that targets the brain's appetite control center, reduces hunger, and slows stomach emptying
Am I a Good Candidate
CMS indicates in its March 2025 letter that rescinding HRSN guidance does not nullify existing HRSN approvals but going forward they will consider HRSN / SDOH requests on a case-by-case basis
Yes, you can generally take semaglutide while on levothyroxine, though there are important considerations for proper administration and monitoring